DNA damage checkpoint response to aflatoxin B1

Area of Science:

• Toxicology
• Molecular Biology
• Cancer Research

Background:

• Aflatoxin B1 (AFB1) is a potent carcinogen found in food, posing a significant health risk despite regulatory efforts.
• AFB1 requires metabolic activation by cytochrome P450 enzymes to form a reactive epoxide intermediate.

Purpose of the Study:

• To elucidate the molecular mechanisms by which AFB1 induces DNA damage and contributes to cancer development.
• To investigate the link between AFB1-induced mutations and specific cancer types, particularly hepatocellular carcinoma.

Main Methods:

• Analysis of AFB1-DNA adducts in human tissue samples.
• Investigating the role of cytochrome P450 enzymes in AFB1 bioactivation.
• Examining AFB1-induced mutations in key cancer-related genes like ATM and TP53.
• Assessing the impact of AFB1 on cell cycle checkpoints and DNA repair mechanisms.

Main Results:

• High levels of AFB1-DNA adducts were found in both normal and tumor tissues from cancer patients.
• AFB1-8,9-epoxide formation leads to irreversible guanine adducts, causing G-to-T transversions.
• AFB1 exposure disrupts ATM kinase function, impairing G2/M cell cycle checkpoint control.
• The study observed a strong correlation between AFB1-induced mutations and TP53 mutations in hepatocellular cancer cases.

Conclusions:

• AFB1 exposure is a critical factor in the development of hepatocellular carcinoma through the induction of mutagenic DNA adducts and genomic instability.
• TP53 mutations serve as a biomarker for AFB1 exposure and an indicator of increased liver cancer risk.